Brief: Ose Immunotherapeutics: Successful Capital Increase Of 18.6 Million Euros

Ose Immunotherapeutics SA

18/11/2020 06:45

Nov 18 (Reuters) - Ose Immunotherapeutics SA  OSE.PA :
    * ANNOUNCES A SUCCESSFUL CAPITAL INCREASE OF € 18.6 M BY
PRIVATE
PLACEMENT
    * OFFERING CLOSE TO 2.5 TIMES OVERSUBSCRIBED VERSUS THE
INITIAL
MINIMUM TARGET
    * COMPANY REINFORCES ITS FINANCIAL VISIBILITY UNTIL THE
FIRST
QUARTER OF 2022
    * COMPANY RECALLS THAT IT HAS REQUESTED EURONEXT PARIS TO
SUSPEND
THE TRADING OF ITS SHARES AS FROM MONDAY, NOVEMBER 16 BEFORE
MARKET OPENING
    * SHARE TRADING WILL RESUME ON WEDNESDAY, NOVEMBER 18 AT
MARKET
OPENING
    * SETTLEMENT-DELIVERY OF THE OFFERING SHOULD TAKE PLACE ON
20
NOVEMBER

Source text: https://bit.ly/32ViNDR
Further company coverage:  OSE.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7785110;))